Adherence to doxycycline for uncomplicated genitourinary chlamydia: A prospective observational study
Abstract Objectives Since 2020, the Center for Disease Control and Prevention (CDC) no longer recommends single‐dose azithromycin as first‐line therapy for uncomplicated genitourinary chlamydia, advising instead a 7‐day course of doxycycline. Our study investigates self‐reported adherence to the new...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-04-01
|
| シリーズ: | Journal of the American College of Emergency Physicians Open |
| オンライン･アクセス: | https://doi.org/10.1002/emp2.13137 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|